A controversial US-backed $1.6 million vaccine trial involving 14,000 newborns in West Africa has been cancelled
Read the full story on Business Insider AfricaA controversial US-funded hepatitis B vaccine trial involving 14,000 newborns in Guinea-Bissau has been cancelled after the government refused to authorise the research, following international criticism over its proposed design and the risks it could pose to babies.
This story was written and published by Business Insider Africa. Business.co.za shows its headline and teaser from the publisher’s RSS feed and links to the original.